Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002707814 | SCV003555646 | uncertain significance | Inborn genetic diseases | 2021-01-06 | criteria provided, single submitter | clinical testing | The c.3932A>G (p.N1311S) alteration is located in exon 17 (coding exon 17) of the MED13L gene. This alteration results from a A to G substitution at nucleotide position 3932, causing the asparagine (N) at amino acid position 1311 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
3billion | RCV004725577 | SCV005329121 | likely benign | Cardiac anomalies - developmental delay - facial dysmorphism syndrome | 2024-09-20 | criteria provided, single submitter | clinical testing | The variant was identified in at least one patient who was diagnosed with a different variant in another gene and showed no symptoms related to the gene containing the variant in question. |